Resveratrol Alleviates Inflammation in Polycystic Ovary Syndrome by Inhibiting Absent in Melanoma 2 Expression
Phytotherapy Research · 2026
DOI: 10.1002/ptr.70374 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phytotherapy Research, 2026. Verfasst von Qianjie Zhang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Reproductive Medical Center, Renmin Hospital of Wuhan University, Hubei Clinical Research Center for Assisted Fertility and Embryo Development, Wuhan…. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome, Resveratrol, Inflammation, DNA-Binding Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 67 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Hubei Province Traditional Chinese Medicine Research Project, Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
Since chronic inflammation is a typical feature of polycystic ovary syndrome (PCOS), both clinical and experimental studies have demonstrated that resveratrol (RES) can effectively alleviate it. However, the underlying mechanism remains unclear. To further investigate this, granulosa cells (GCs) derived from PCOS patients, lipopolysaccharide (LPS)‐treated human granulosa cells (KGN), LPS‐induced chronic inflammation mouse models, and dehydroepiandrosterone (DHEA)‐induced PCOS mouse models were treated with RES. The expression of inflammatory cytokines, including interleukin (IL)‐6, IL‐1β, chemoattractant protein‐1 (MCP‐1), and cyclooxygenase‐2 (COX2), as well as absent in melanoma 2 (AIM2), was examined. Additionally, ovarian morphological changes in these mouse models were assessed using hematoxylin–eosin (HE) staining. The results showed that the expression of these inflammatory cytokines and AIM2 increased significantly in GCs derived from PCOS patients and LPS‐induced KGN cells, as well as in the ovaries of LPS‐induced chronic inflammation and DHEA‐induced PCOS mouse models. Furthermore, blocking AIM2 in LPS‐treated KGN cells and mice with LPS‐induced inflammation or PCOS significantly reduced the upregulation of inflammatory cytokines, similar to the results observed following RES treatment. In addition, LPS‐induced phosphorylation of the JAK2/STAT3 pathway in KGN cells was completely abolished by RES treatment. Notably, LPS‐induced upregulation of AIM2 and these inflammatory cytokines was completely reversed by blocking the JAK2/STAT3 pathway using AZD‐1480 and SH‐4‐54, respectively. Further in vivo studies showed that ovarian morphological and estrous cycle disturbances in DHEA‐induced PCOS mouse models were effectively ameliorated by RES and A151. In conclusion, RES alleviates chronic inflammation in PCOS by inhibiting AIM2 via blocking the JAK2/STAT3 pathway. Our findings suggest that the targeted inhibition of AIM2 could represent a novel therapeutic approach for PCOS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Reproductive Medical Center, Renmin Hospital of Wuhan University, Hubei Clinical Research Center for Assisted Fertility and Embryo Development, Wuhan, China.
- Jiangsu Key Laboratory for Food Quality and Safety-State Key Laboratory Cultivation Base of Ministry of Science and Technology; Key Laboratory of Animal Breeding and Reproduction, Institute of Animal Science, Jiangsu Ac…
- Jiangsu Provincial Engineering Research Center for Precision Animal Breeding, Nanjing, China.
- College of Animal Science and Technology, Nanjing Agricultural University, Nanjing, China.
- Department of Traditional Chinese Medicine, Renmin Hospital of Wuhan University, Wuhan, China.
- Department of Obstetrics and Gynaecology, BC Children's Hospital Research Institute, University of British Columbia, Vancouver, British Columbia, Canada.
ORCID-Profile: Hui Li, Jing Yang, Enfeng Song, Saijiao Li
Förderung
- National Natural Science Foundation of China
- Hubei Province Traditional Chinese Medicine Research Project
- Fundamental Research Funds for the Central Universities
- Natural Science Foundation of Hubei Province Innovation and Development Joint Fund Project
- Health Commission of Hubei Province
- Natural Science Foundation of Jiangsu Province
Zitieren
APA
Zhang, Q., Li, H., Meng, Y., Zhao, W., Li, W., Dai, C., Li, B., Cheng, J., Yang, J., Hu, J., Song, E., Leung, P. C. K., & Li, S. (2026). Resveratrol Alleviates Inflammation in Polycystic Ovary Syndrome by Inhibiting Absent in Melanoma 2 Expression. Phytotherapy Research. https://doi.org/10.1002/ptr.70374
Vancouver
Zhang Q, Li H, Meng Y, Zhao W, Li W, Dai C, et al. Resveratrol Alleviates Inflammation in Polycystic Ovary Syndrome by Inhibiting Absent in Melanoma 2 Expression. Phytotherapy Research. 2026. doi:10.1002/ptr.70374
BibTeX
@article{Zhang2026,
author = {Zhang, Qianjie and Li, Hui and Meng, Yicen and Zhao, Weimin and Li, Wei and Dai, Chaohui and Li, Bixia and Cheng, Jinhua and Yang, Jing and Hu, Jiacai and Song, Enfeng and Leung, Peter C K and Li, Saijiao},
title = {Resveratrol Alleviates Inflammation in Polycystic Ovary Syndrome by Inhibiting Absent in Melanoma 2 Expression},
journal = {Phytotherapy Research},
year = {2026},
doi = {10.1002/ptr.70374}
}
EUVIMED